You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ICL670

Showing 26 - 50 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transfusional Iron Overload, ß-thalassemia Major, Pediatric Rare Anemia Trial in France, Italy (Deferasirox)

Completed
Has Results
  • Transfusional Iron Overload
  • +2 more
  • Lyon, France
  • +3 more
Feb 12, 2017

Iron Overload Trial in Leipzig (Deferasirox)

Completed
  • Iron Overload
  • Leipzig, Germany
    Novartis Investigative Site
Nov 16, 2016

Hemoglobinopathies, MDS, Other Inherited or Acquired Anaemia Trial in Australia (deferasirox)

Completed
  • Hemoglobinopathies
  • +6 more
  • Adelaide, Australia
  • +3 more
Feb 20, 2017

Iron Mediated Vascular Disease in Sickle Cell Anemia Patients

Completed
  • Sickle Cell Disease
    • Los Angeles, California
      Children's Hospital Los Angeles
    Jan 9, 2019

    Myelodysplastic Syndrome, Transfusional Iron Overload Trial in Worldwide (Deferasirox)

    Terminated
    Has Results
    • Myelodysplastic Syndrome
    • Transfusional Iron Overload
    • Caen, Cedex, France
    • +9 more
    Mar 1, 2017

    Myelodysplastic Syndrome, Thalassemia Trial in Moscow, Saint-Petersburg, St. Petersburg (Deferasirox)

    Completed
    • Myelodysplastic Syndrome
    • Thalassemia
    • Moscow, Russian Federation
    • +2 more
    Dec 8, 2016

    Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major Trial in Turkey

    Completed
    Has Results
    • Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major
    • ICL670
    • Ankara, Turkey
    • +5 more
    Sep 12, 2016

    MDS, Hemosiderosis Trial in Italy (Deferasirox)

    Completed
    • Myelodysplastic Syndromes
    • Hemosiderosis
    • Alessandria, Italy
    • +16 more
    Nov 21, 2016

    Beta-Thalassemia, Hemosiderosis Trial in Worldwide (deferasirox)

    Completed
    • Beta-Thalassemia
    • Hemosiderosis
    • Cairo, Egypt
    • +4 more
    Feb 28, 2017

    Low and Int 1-risk Myelodysplastic Syndrome Trial in Worldwide (Deferasirox DFX, DT, Erythropoietin alpha, Deferasirox DFX, FCT)

    Completed
    Has Results
    • Low and Int 1-risk Myelodysplastic Syndrome
    • Deferasirox DFX, DT
    • +2 more
    • Oran, Algeria
    • +29 more
    Oct 4, 2018

    Thalassemia, Iron Overload, Hemochromatosis Trial run by the NIDDK (Nifedipine, Phlebotomy, Urinalysis)

    Completed
    • Thalassemia
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 30, 2017

    Atrial Fibrillation, Percutaneous Coronary Intervention Trial in Worldwide (Dabigatran Etexilate 110mg, Warfarin 3mg, Aspirin)

    Completed
    Has Results
    • Atrial Fibrillation
    • Percutaneous Coronary Intervention
    • Dabigatran Etexilate 110mg
    • +6 more
    • Birmingham, Alabama
    • +420 more
    Jul 27, 2018

    Melanoma, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Skin Trial in New York (Poly-ICLC)

    Terminated
    Has Results
    • Melanoma
    • +5 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Dec 21, 2017

    Anemia, Sickle Cell, Transfusion Hemosiderosis Trial in Los Angeles (deferasirox)

    Terminated
    Has Results
    • Anemia, Sickle Cell
    • Transfusion Hemosiderosis
    • Los Angeles, California
      Childrens Hospital Los Angeles
    Dec 15, 2016

    Transfusional Iron Overload Trial in Italy (Deferasirox)

    Completed
    • Transfusional Iron Overload
    • Cagliari, Italy
    • +3 more
    Mar 18, 2015

    Children Aged 2 to <6 Years With Transfusional Iron Overload

    Completed
    • Anemia
    • Mobile, Alabama
    • +22 more
    Dec 26, 2015

    Transfusional Iron Overload, Transfusional Hemosiderosis Trial in Worldwide (Core Study: Deferasirox, Core Study: Deferoxamine,

    Completed
    Has Results
    • Transfusional Iron Overload
    • Transfusional Hemosiderosis
    • Core Study: Deferasirox
    • +5 more
    • Toronto, Ontario, Canada
    • +20 more
    Aug 13, 2014

    Beta-Thalassemia Trial in United States (ICL670, deferoxamine)

    Completed
    • Beta-Thalassemia
    • Los Angeles, California
    • +6 more
    Apr 18, 2012

    Non-alcoholic Steatohepatitis, Increased Iron Storage / Disturbed Distribution Trial in Germany (Exjade)

    Completed
    • Non-alcoholic Steatohepatitis
    • Increased Iron Storage / Disturbed Distribution
    • Balingen/Hechingen, Germany
    • +8 more
    Jul 19, 2012

    Iron Overload Trial in Spain (deferasirox)

    Completed
    • Iron Overload
    • Andalucia, Spain
    • +8 more
    Apr 27, 2012

    Beta-thalassemia Major, Sickle Cell Disease, Iron Hemosiderosis Trial in Cairo (DFP (ferriprox) and deferasirox (ICL 670), DFP,

    Unknown status
    • Beta-thalassemia Major
    • +2 more
    • DFP (ferriprox) and deferasirox (ICL 670)
    • DFP, DFO
    • Cairo, Egypt
      Pediatric Hematology clinic, Ain Shams University
    Feb 3, 2012

    Sickle Cell Disease Trial in Worldwide (ICL670)

    Completed
    Has Results
    • Sickle Cell Disease
    • ICL670
    • Mobile, Alabama
    • +38 more
    May 3, 2011

    Transfusional Iron Overload in ß-thalassemia Trial in Worldwide (Deferasirox)

    Completed
    Has Results
    • Transfusional Iron Overload in β-thalassemia
    • Los Angeles, California
    • +48 more
    May 24, 2011

    Anemia, Hemosiderosis Trial in Worldwide (Deferasirox)

    Completed
    Has Results
    • Anemia
    • Hemosiderosis
    • Oakland, California
    • +27 more
    Apr 15, 2011

    Sickle Cell Disease, Iron Overload, Hemolytic Anemia Trial in Canada, United States (Deferasirox (ICL670), Deferoxamine (DFO))

    Completed
    Has Results
    • Sickle Cell Disease
    • +2 more
    • Deferasirox (ICL670)
    • Deferoxamine (DFO)
    • Birmingham, Alabama
    • +58 more
    May 23, 2011